CN103989953A - Traditional Chinese medicinal composition for treating infantile paralysis - Google Patents
Traditional Chinese medicinal composition for treating infantile paralysis Download PDFInfo
- Publication number
- CN103989953A CN103989953A CN201410253219.2A CN201410253219A CN103989953A CN 103989953 A CN103989953 A CN 103989953A CN 201410253219 A CN201410253219 A CN 201410253219A CN 103989953 A CN103989953 A CN 103989953A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicine
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine, and particularly discloses a traditional Chinese medicinal composition for treating infantile paralysis. The traditional Chinese medicinal composition is prepared by using nux vomica, liquidambar formosana hance, scutellaria baicalensis, coptis chinensis, radix angelicae pubescentis, radix stephaniae tetrandrae, rhizoma atractylodis, uniflower swisscentaury root, common calanthe herb and liquorice in a certain parts by weight. The traditional Chinese medicinal composition is scientific in compatibility, strong and stable in medical effect and quick in efficacy, does not have side effects, and ensures that infantile paralysis is difficult to relapse.
Description
Technical field
The invention belongs to lunar physics technique field, particularly a kind of Chinese medicine composition for the treatment of poliomyelitis.
Background technology
Poliomyelitis has another name called " poliomyelitis ", it is the acute infectious disease being caused by specificity neurotropic virus, damage ventricornual motor neuron, its symptom main manifestations is: heating, acroesthesia, with gastrointestinal or upper airway symptoms, limb paralysis and slowness paralysis.
The medicine of at present, treating poliomyelitis mostly both at home and abroad is the medicines such as analgesics, tranquilizer or bendazol.Last time, medicine had certain curative effect to treatment poliomyelitis, but had larger side effect and the shortcoming such as therapeutic effect is not obvious.
Summary of the invention
The present invention is in order to make up the deficiency of existing medicine, the Chinese medicine composition of the poliomyelitis that provide a kind of and have no side effect, therapeutic effect is good.
The present invention is achieved through the following technical solutions:
Treat a Chinese medicine composition for poliomyelitis, its active component is comprised of the raw material of following parts by weight: Semen Strychni 18-22 part, Fructus Liquidambaris 9-15 part, Radix Scutellariae 9-15 part, Rhizoma Coptidis 12-22 part, Radix Angelicae Pubescentis 7-12 part, Radix Stephaniae Tetrandrae 15-20 part, Rhizoma Atractylodis 7-12 part, Radix Rhapontici 7-12 part, Herba seu Radix Calanthes 5-8 part, Radix Glycyrrhizae 3-7 part.
The weight proportion of its preferred each active component is: 18 parts of Semen Strychni, 11 parts of Fructus Liquidambaris, 12 parts of Radix Scutellariaes, 18 parts of Rhizoma Coptidis, 9 parts of Radix Angelicae Pubescentiss, 16 parts of Radixs Stephaniae Tetrandrae, 9 parts of Rhizoma Atractylodis, 9 parts of Radix Rhapontici, 6 parts of Herba seu Radix Calanthess, 5 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is powder or pill.After various raw materials are cleaned up, co-grinding, crosses 100 mesh sieves, makes powder or pill.
The pharmaceutical characteristic of each activated feedstock is:
Semen Strychni: be Strychnos nux-vomica Linn. Loganiaceae Strychnos.Detumescence poison, removing heat from blood.Cure mainly numb limbs and tense tendons, paralysis, inappetence, mass in the abdomen, carbuncle pyogenic infections from tumour or sore, laryngopharynx swelling and pain.
Fructus Liquidambaris: be Hamamelidaceae Plants Chinese sweet gum
liquidambar formosanathe drying and ripening infructescence of Hance.Promoting blood circulation and detumescence, granulation promoting pain relieving.Be applicable to sore carbuncle, the diseases such as wound hemorrhage.
Radix Scutellariae: be a kind of plant of Labiatae Scutellaria.Heat clearing and damp drying, eliminating fire and detoxication.Cure mainly the diseases such as epidemic febrile disease, upper respiratory tract infection, cough due to lung-heat, damp and hot jaundice, pneumonia, dysentery, hemoptysis, conjunctival congestion, frequent fetal movement, hypertension, carbuncle furuncle.
Rhizoma Coptidis: belong to Ranunculaceae, Coptis herbaceos perennial.Heat clearing and damp drying, eliminating fire and detoxication.For damp and hot feeling of fullness, vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, toothache, quenches one's thirst, carbuncle furuncle; External treatment eczema, eczema, auditory meatus is suppurated.
Radix Angelicae Pubescentis: be the dry root of samphire Angelica pubescens.Expelling wind and dampness; Dispersing cold for relieving pain.For anemofrigid-damp arthralgia; Lumbocrural pain; Few cloudy volt wind headache, headache toothache.
Radix Stephaniae Tetrandrae: be Menispermaceae woody climber.Inducing diuresis to remove edema, wind-expelling pain-stopping.Edema beriberi, dysuria, eczema sore, rheumatic arthralgia, vascular hypertension.
Rhizoma Atractylodis: be Atractylodes lancea (Thunb.) DC. Compositae, [WTBX perennial herb.Dampness, change turbid, pain relieving.Cure mainly the transporting imbalance that the spleen being blocked by dampness causes, inappetence, vomiting is unhappy, and abdominal distention is had loose bowels, arthralgia.
Radix Rhapontici: be feverfew centaurea monanthos Georgi Rhaponticum uni-florum(L.) root of DC. or Radix Echinopsis Echinps latifolius Tausch..Heat-clearing and toxic substances removing, evacuation of pus detumescence, eliminating carbuncle, stimulating milk secretion, relaxing muscles and tendons is promoted blood circulation.For acute mastitis, swell and ache, carbuncle carbuncle on the back, scrofula sore, galactostasis, arthralgia chiefly caused by damp pathogen contracture, arthralgia, toxic-heat and blood stasis, bleeding hemorrhoids.
Herba seu Radix Calanthes: be perennial herb.Eliminating stagnation, removing toxic substances, invigorates blood circulation, relaxing muscles and tendons.Cure mainly scrofula, tonsillitis, hemorrhoid, traumatic injury.
Radix Glycyrrhizae: be Glycyrrhiza uralensis Fisch. pulse family, Glycyrrhiza perennial herb.Cure mainly heat-clearing and toxic substances removing, expelling phlegm for arresting cough, gastral cavity abdomen.
In formula, Semen Strychni, Fructus Liquidambaris, Radix Scutellariae, Rhizoma Coptidis are mainly used in heat-clearing and toxic substances removing, reducing swelling and alleviating pain, and above-mentioned four medicines share and cure mainly numb limbs and tense tendons, paralysis, therefore be monarch drug.Radix Angelicae Pubescentis, Radix Stephaniae Tetrandrae, Rhizoma Atractylodis, Radix Rhapontici are mainly used in dispersing cold for relieving pain, and relaxing muscles and tendons is promoted blood circulation, and four medicines share has the effect that strengthens removing toxic substances, pain relieving, therefore be ministerial drug.Herba seu Radix Calanthes cures mainly scrofula, and traumatic injury also can be alleviated the strong of monarch drug, therefore be adjuvant drug.In the Radix Glycyrrhizae side of drawing, all medicines are to reach focus, for making medicine.
In sum, medicine of the present invention is through science compatibility, strong drug action, the efficacy of a drug rapidly, efficacy stability, there is heat-clearing and toxic substances removing, relax through promoting blood circulation, the effects such as dispersing cold for relieving pain.Treatment poliomyelitis is had to good result, and there is the feature such as be difficult for recurring, having no side effect.
The specific embodiment
Embodiment 1:
Get 18 parts of Semen Strychni, 9 parts of Fructus Liquidambaris, 9 parts of Radix Scutellariaes, 12 parts of Rhizoma Coptidis, 7 parts of Radix Angelicae Pubescentiss, 15 parts of Radixs Stephaniae Tetrandrae, 7 parts of Rhizoma Atractylodis, 7 parts of Radix Rhapontici, 5 parts of Herba seu Radix Calanthess, 3 parts, Radix Glycyrrhizae.Above-mentioned raw materials is cleaned up, beat powder and mix, make powder or pill, quantitatively take.
Usage and dosage: oral, three times on the one, each 10～15g, one after each meal.
Embodiment 2:
Get 22 parts of Semen Strychni, 15 parts of Fructus Liquidambaris, 15 parts of Radix Scutellariaes, 22 parts of Rhizoma Coptidis, 12 parts of Radix Angelicae Pubescentiss, 20 parts of Radixs Stephaniae Tetrandrae, 12 parts of Rhizoma Atractylodis, 12 parts of Radix Rhapontici, 8 parts of Herba seu Radix Calanthess, 7 parts, Radix Glycyrrhizae.Above-mentioned raw materials is cleaned up, beat powder and mix, make powder or pill, quantitatively take.
Usage and dosage: oral, three times on the one, each 10～15g, one after each meal.
Embodiment 3:
Get 18 parts of Semen Strychni, 11 parts of Fructus Liquidambaris, 12 parts of Radix Scutellariaes, 18 parts of Rhizoma Coptidis, 9 parts of Radix Angelicae Pubescentiss, 16 parts of Radixs Stephaniae Tetrandrae, 9 parts of Rhizoma Atractylodis, 9 parts of Radix Rhapontici, 6 parts of Herba seu Radix Calanthess, 5 parts, Radix Glycyrrhizae.Above-mentioned raw materials is cleaned up, beat powder and mix, make powder or pill, quantitatively take.
Usage and dosage: oral, three times on the one, each 10～15g, one after each meal.
A kind of clinical trial for the treatment of the Chinese medicine composition result of use of poliomyelitis of the present invention:
(1) object of study
(2) inventor selects polio victim 90 people, male 45 examples wherein, and female's 45 examples, the age is between 3～8 years old.Divide 3 groups, there are respectively each 15 people of men and women in every group.Group 1 is used the Chinese medicine composition of embodiment 1, and group 2 is used the Chinese medicine composition of embodiment 2, and group 3 is used the Chinese medicine composition of embodiment 3.
(2) Therapeutic Method
Oral, three times on the one, each 10～15g, one after each meal.According to conditions of patients weight, calculate treatment time, patients with mild was taken about 30 days, and severe case serve on 60 days and can fully recover.
(3) curative effect determinate standard
Cure: symptom all disappears; Main physics and chemistry detects index and is normally.
Effective: symptomatology is eliminated or cardinal symptom is eliminated; Physics and chemistry detects index normal.
Effective: cardinal symptom disappears substantially; Main physics and chemistry detects index and makes moderate progress.
Invalid: it is front unchanged with treatment that main physics and chemistry detects index.
(4) clinical effectiveness
The clinical effectiveness of group 1 is: clinical cure: 22 examples (73%), and effective 3 examples (10%), effective 2 examples (7%), invalid 3 examples (10%), total effective rate is 90%.
The clinical effectiveness of group 2 is: clinical cure: 20 examples (67%), and effective 3 examples (10%), effective 1 example (3%), invalid 6 examples (20%), total effective rate is 83%.
The clinical effectiveness of group 3 is: clinical cure: 24 examples (80%), and effective 3 examples (10%), effective 2 examples (7%), invalid 1 example (3%), total effective rate is 97%.
By above clinical trial, can be found out, embodiment 3 is optimum weight proportioning of the present invention.
Claims (3)
1. the Chinese medicine composition for the treatment of poliomyelitis, is characterized in that: the material medicine of this Chinese medicine composition and parts by weight are: Semen Strychni 18-22 part, Fructus Liquidambaris 9-15 part, Radix Scutellariae 9-15 part, Rhizoma Coptidis 12-22 part, Radix Angelicae Pubescentis 7-12 part, Radix Stephaniae Tetrandrae 15-20 part, Rhizoma Atractylodis 7-12 part, Radix Rhapontici 7-12 part, Herba seu Radix Calanthes 5-8 part, Radix Glycyrrhizae 3-7 part.
2. the Chinese medicine composition for the treatment of poliomyelitis according to claim 1, is characterized in that: the material medicine of this Chinese medicine composition and parts by weight are: 18 parts of Semen Strychni, 11 parts of Fructus Liquidambaris, 12 parts of Radix Scutellariaes, 18 parts of Rhizoma Coptidis, 9 parts of Radix Angelicae Pubescentiss, 16 parts of Radixs Stephaniae Tetrandrae, 9 parts of Rhizoma Atractylodis, 9 parts of Radix Rhapontici, 6 parts of Herba seu Radix Calanthess, 5 parts, Radix Glycyrrhizae.
3. according to the Chinese medicine composition of the treatment poliomyelitis described in claim 1 or 2 or 3, it is characterized in that: described Chinese medicine composition is powder or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410253219.2A CN103989953A (en) | 2014-06-10 | 2014-06-10 | Traditional Chinese medicinal composition for treating infantile paralysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410253219.2A CN103989953A (en) | 2014-06-10 | 2014-06-10 | Traditional Chinese medicinal composition for treating infantile paralysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103989953A true CN103989953A (en) | 2014-08-20 |
Family
ID=51304453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410253219.2A Withdrawn CN103989953A (en) | 2014-06-10 | 2014-06-10 | Traditional Chinese medicinal composition for treating infantile paralysis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103989953A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362905A (en) * | 2015-11-25 | 2016-03-02 | 苏吉永 | Traditional Chinese medicine for treating poliomyelitis with pathogens diffusing into channels and collaterals |
-
2014
- 2014-06-10 CN CN201410253219.2A patent/CN103989953A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362905A (en) * | 2015-11-25 | 2016-03-02 | 苏吉永 | Traditional Chinese medicine for treating poliomyelitis with pathogens diffusing into channels and collaterals |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772778B (en) | Traditional Chinese medicine composition for treating summer heat-dampness | |
| CN102145114B (en) | Novel traditional Chinese medicine for treating cold | |
| CN102973862B (en) | Chinese medicine preparation for treating skin itch | |
| CN104740202A (en) | Medicine for treating skin itch | |
| CN103432374A (en) | Medicine for treating pneumonia of pig | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN103585401A (en) | Traditional Chinese medicine composition for treating bird flu and preparation method therefor. | |
| CN104958448A (en) | Medicine for treating puerperal infection | |
| CN101623352A (en) | Medicine for treating acne and preparation method thereof | |
| CN102100817A (en) | Chinese medicinal preparation for treating infection of upper respiratory tracts | |
| CN104352869A (en) | Traditional Chinese medicine for treating acute upper respiratory infection and preparation method thereof | |
| CN104189784A (en) | Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation | |
| CN103933365A (en) | Internal medicine for treating phthisis | |
| CN101181437B (en) | Chinese medicine composition orally taken for curing acute tonsillitis | |
| CN103656090B (en) | A kind of enema and application thereof for the treatment of ulcerative colitis | |
| CN103301210B (en) | Traditional Chinese medicine for treating varicosity | |
| CN102389517A (en) | Traditional Chinese medicine for treating fever with swollen head | |
| CN103989953A (en) | Traditional Chinese medicinal composition for treating infantile paralysis | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN105477201A (en) | Traditional Chinese medicine preparation for treating influenza and preparation method of traditional Chinese medicine preparation for treating influenza | |
| CN105311520A (en) | Traditional Chinese medicine liniment for treating traumatic injuries | |
| CN104491825A (en) | Traditional Chinese medicine ointment for treating canker sores | |
| CN104666806A (en) | Traditional Chinese medicine for treating epidemic meningitis | |
| CN103432466A (en) | Female pelvic inflammatory disease treatment traditional Chinese medicine composition and preparation method thereof | |
| CN102631660A (en) | Chinese medicament for treating intestinal obstruction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 325015 Zhejiang Province, Ouhai District, No. 104 State Road, south section of the white elephant, No. 437, No. Applicant after: Guo Gensong Address before: 311404, Zhejiang, Hangzhou Province, Fuyang City cave Town, check source village, deep dock No. 31 Applicant before: Guo Gensong |
|
| COR | Change of bibliographic data | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20140820 |
|
| WW01 | Invention patent application withdrawn after publication |